Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploiting genotypic differences to identify genes important for EAE development.

Scott A Jelinsky1, Joy S Miyashiro, Kathryn A Saraf

  • 1Molecular Profiling and Biomarker Discover, Biological Technologies Department, Wyeth Research, 87 Cambridge Park Drive, Cambridge MA 02140, USA. sjelinsky@wyeth.com

Journal of the Neurological Sciences
|October 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

American journal of hematology·2026
Same author

Erratum: Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitis.

Nature communications·2026
Same author

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA oncology·2026
Same author

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Blood advances·2026

Investigating gene expression in mouse models of multiple sclerosis (MS) revealed key genes common across different genetic deficiencies. This approach enhances the identification of genes critical for autoimmune disease development, offering insights into human MS.

Area of Science:

  • Neuroimmunology
  • Genomics
  • Autoimmune Diseases

Background:

  • Experimental autoimmune encephalomyelitis (EAE) models multiple sclerosis (MS) and is T helper type 1 (Th1) cell-driven.
  • Interleukin-12 (IL-12) and interferon-gamma (IFN-γ) are crucial for Th1 cell development, yet EAE progresses in their absence.
  • Identifying critical genes in EAE pathogenesis is essential for understanding MS.

Purpose of the Study:

  • To identify genes critical for EAE development using microarray analysis.
  • To compare gene expression profiles in wild-type, IFN-γ -/-, and IL-12 -/- mice with EAE.
  • To determine the relevance of identified genes to human multiple sclerosis.

Main Methods:

  • Microarray analysis of central nervous system (CNS) tissues from EAE-affected mice (wild-type, IFN-γ -/-, IL-12 -/-).

Related Experiment Videos

  • Comparative gene expression profiling across different genetic backgrounds and disease states.
  • Correlation analysis of EAE-regulated genes with gene expression in human MS tissues.

    • Main Results:

    • Over 500 genes were regulated in at least one mouse genotype; 94 genes were consistently regulated across all three.
    • Of the 94 commonly regulated genes, 17 were also upregulated in the spleen during EAE.
    • A majority of genes regulated in EAE were also found to be regulated in diseased human MS tissues.

    Conclusions:

    • Analyzing gene expression across multiple genetic conditions in EAE models improves the identification of disease-critical genes.
    • Genes consistently regulated in EAE models show higher relevance to human multiple sclerosis.
    • This multi-genotype approach offers a more robust strategy for discovering therapeutic targets for MS.